We believe that this knowledge contributed to a better understanding of the role of glucagon on the increased susceptibility and worsening of sepsis in diabetes, which may benefit future investigations of therapeutic strategies for septic diabetic patients. This evidence concerns the gene GCG and diabetes mellitus.